Search Page

1

Cite

Share

Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.

Hines LE, Ceron-Cabrera D, Romero K, Anthony M, Woosley RL, Armstrong EP, Malone DC. Hines LE, et al. Among authors: romero k. Clin Ther. 2011 Jan;33(1):36-45. doi: 10.1016/j.clinthera.2011.01.021. Clin Ther. 2011. PMID: 21397772

Cite

Share

2

Cite

Share

Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.

Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL. Anthony M, et al. Among authors: romero k. Clin Pharmacol Ther. 2009 Oct;86(4):425-9. doi: 10.1038/clpt.2009.95. Epub 2009 Jul 8. Clin Pharmacol Ther. 2009. PMID: 19587643

Cite

Share

3

Cite

Share

The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.

Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL. Romero K, et al. Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165. Clin Pharmacol Ther. 2009. PMID: 19763117

Cite

Share

4

Cite

Share

The future is now: model-based clinical trial design for Alzheimer's disease.

Romero K, Ito K, Rogers JA, Polhamus D, Qiu R, Stephenson D, Mohs R, Lalonde R, Sinha V, Wang Y, Brown D, Isaac M, Vamvakas S, Hemmings R, Pani L, Bain LJ, Corrigan B; Alzheimer's Disease Neuroimaging Initiative; Coalition Against Major Diseases. Romero K, et al. Clin Pharmacol Ther. 2015 Mar;97(3):210-4. doi: 10.1002/cpt.16. Epub 2014 Dec 27. Clin Pharmacol Ther. 2015. PMID: 25669145 Free PMC article.

Cite

Share

5

Cite

Share

Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool.

Romero K, Clay R, Hanna D. Romero K, et al. Clin Infect Dis. 2015 Aug 15;61 Suppl 1:S5-9. doi: 10.1093/cid/civ424. Clin Infect Dis. 2015. PMID: 26224771

Cite

Share

6

Cite

Share

Medical decision support systems and therapeutics: The role of autopilots.

Woosley RL, Whyte J, Mohamadi A, Romero K. Woosley RL, et al. Among authors: romero k. Clin Pharmacol Ther. 2016 Feb;99(2):161-4. doi: 10.1002/cpt.259. Epub 2015 Oct 22. Clin Pharmacol Ther. 2016. PMID: 26352903

Cite

Share

7

Cite

Share

Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death.

Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S. Woosley RL, et al. Among authors: romero k. Drug Saf. 2017 Jun;40(6):465-474. doi: 10.1007/s40264-017-0519-0. Drug Saf. 2017. PMID: 28275963 Review.

Cite

Share

8

Cite

Share

Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs.

Ahamadi M, Conrado DJ, Macha S, Sinha V, Stone J, Burton J, Nicholas T, Gallagher J, Dexter D, Bani M, Boroojerdi B, Smit H, Weidemann J, Chen C, Yang M, Maciuca R, Lawson R, Burn D, Marek K, Venuto C, Stafford B, Akalu M, Stephenson D, Romero K; Critical Path for Parkinson's (CPP) Consortium. Ahamadi M, et al. Among authors: romero k. Clin Pharmacol Ther. 2020 Mar;107(3):553-562. doi: 10.1002/cpt.1634. Epub 2019 Dec 5. Clin Pharmacol Ther. 2020. PMID: 31544231 Free PMC article.

Cite

Share

9

Cite

Share

Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open Data.

Conrado DJ, Burton J, Hill D, Willis B, Sinha V, Stone J, Coello N, Wang W, Chen D, Nicholas T, Gold M, Hartley E, Kern VD, Romero K. Conrado DJ, et al. Among authors: romero k. Clin Pharmacol Ther. 2020 Apr;107(4):903-914. doi: 10.1002/cpt.1766. Epub 2020 Mar 7. Clin Pharmacol Ther. 2020. PMID: 31899810

Cite

Share

10

Cite

Share

Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.

Conrado DJ, Duvvuri S, Geerts H, Burton J, Biesdorf C, Ahamadi M, Macha S, Hather G, Francisco Morales J, Podichetty J, Nicholas T, Stephenson D, Trame M, Romero K, Corrigan B; Drug Development Tools in the Alzheimer Disease Continuum (DDT-AD) Working Group. Conrado DJ, et al. Among authors: romero k. Clin Pharmacol Ther. 2020 Apr;107(4):796-805. doi: 10.1002/cpt.1782. Epub 2020 Mar 11. Clin Pharmacol Ther. 2020. PMID: 31955409 Review.

Cite

Share